1. The U.S. Generic & Biosimilar Medicines Savings Report;AAM,2021
2. Accenture (2013), “Life in the New Normal: The Customer Engagement Revolution”.
3. “The long shadow of patent expiration. Generic entry and Rx-to-OTC switches”, Scanner data and price indexes;Berndt,2003
4. A simple model of pharmaceutical price dynamics;Bhattacharya;The Journal of Law and Economics,2003
5. “Patent expiration, entry, and competition in the US pharmaceutical industry”;Caves;Brookings papers on economic activity Microeconomics,1991